Among patients with severe scleroderma, stem cell transplant significantly improved survival compared with cyclophosphamide but was associated with higher mortality and short-term side effects, a study found.
Medscape Medical News
http://ift.tt/2qtRi3N
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου